about
Myocarditis as a form of relapse in two patients with adult Still's disease.Cryptogenic organizing pneumonia (COP), as presentation of rheumatoid arthritis.Severe infections in patients with autoimmune diseases treated with cyclophosphamide.Proliferative Diffuse Glomerulonephritis in Rheumatoid Arthritis.Work instability in rheumatoid arthritis patients from Argentina: prevalence and associated factors.Multiple avascular necrosis in a patient with systemic lupus erythematosus/systemic sclerosis overlap syndrome.Bone marrow edema syndrome of the hip: analysis of 10 cases.Hypothyroidism presenting as puzzling myalgias and cramps in three patients: comment on the article by George.[Acute anterior uveitis associated with the use zoledronic acid]Cardiac valve vegetations in APS, role of long-term anticoagulationAbatacept for treatment of refractory polymyositisCoronary artery aneurysms in Wegener's granulomatosisPortal vein thrombosis in systemic lupus erythematosus associated with anticardiolipin antibodies[Sarcoidosis. Clinical presentation and prognosis]Outcome of Patients With Systemic Rheumatic Diseases Admitted to a Medical Intensive Care UnitA Man With Sicca Symptoms and Bilateral Parotid EnlargementPolyarteritis Nodosa Complicated by Antiphospholipid SyndromeShrinking lungs syndrome, a rare manifestation of systemic lupus erythematosusArtropatías por cristales, una causa infrecuente de quistes poplíteos[Pachydermoperiostosis (primary hypertrophic osteoarthropathy)]Deforming GoutSudden sensorineural hearing loss in Systemic Lupus Erythematosus and Antiphospholipid Syndrome. An Update
P50
Q40385277-F0C29E87-D077-470A-AB9A-255D073FD3B9Q40418482-8A462301-C790-40F1-9E90-DD373164DE2EQ41629899-DFD813A4-1194-4E89-A4AA-3702D68E7C84Q50099736-4C8B62A2-0132-4B2B-B6E4-1587677098CCQ51132948-85014317-11EE-4F59-9CE4-B12CA0CC5378Q51551268-CFC3AAA8-1E4D-4A9C-BEFC-129B5AC7E012Q54514065-3D164C92-F1B4-4BDB-972F-9F66A253EC5FQ54583845-20449AD5-DE63-4D0F-A949-154423A2EB89Q58895861-B6DB14CF-8BCC-44FE-B131-FDEE69DD005EQ58895864-48528621-2560-4A8D-A640-A4EEC03EC312Q58895869-F20F2F9E-BC30-40FC-B8F6-EAEEF21E886FQ58895872-C1E8FED6-CA16-4633-91FD-D4D3FEE02DBDQ58895873-38FCEB37-BAF8-428D-8A79-4D2051CA16FEQ58895877-DA428FA2-662C-4AFF-B5D1-40CDA17B84CBQ58895880-CEB1DB07-C25B-462E-BB34-6AA4869C354DQ58895883-752C4DE7-B2B7-45BE-BC4A-9B3AC5BDA300Q58895885-1A294563-A831-4A00-9D37-9203C1773736Q58895889-E07A7A43-7732-4E9B-8E5D-4BEE9A65D9DBQ58895891-CC9E2E6F-8ABA-4974-A691-B40DAC533035Q58895893-C300F4FB-878C-4602-8B97-E0647244B127Q58895895-85C8D3BF-486E-4DAD-9E3F-6124B9D4E5DDQ91715339-0E8DFB29-7375-43B9-A686-01D6E2AEB8CF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Javier Cavallasca
@ast
Javier Cavallasca
@en
Javier Cavallasca
@es
Javier Cavallasca
@nl
Javier Cavallasca
@sl
type
label
Javier Cavallasca
@ast
Javier Cavallasca
@en
Javier Cavallasca
@es
Javier Cavallasca
@nl
Javier Cavallasca
@sl
prefLabel
Javier Cavallasca
@ast
Javier Cavallasca
@en
Javier Cavallasca
@es
Javier Cavallasca
@nl
Javier Cavallasca
@sl
P106
P21
P31
P496
0000-0003-4621-519X